Aptose Biosciences Inc. | Key People and Executives
William G. Rice
Chairman, President & Chief Executive Officer
Caroline M. Loewy
Director
Erich Maximilian Platzer
Independent Director
Warren Whitehead
Independent Director
Mark D. Vincent
Independent Director
Denis R. Burger
Lead Independent Director
William G. Rice
Chairman, President & Chief Executive Officer
Gregory K. Chow
Chief Financial Officer & Senior Vice President
Ernest Kitt
Vice President-Development & Technical Operations
Stephen B. Howell
Chief Medical Officer
Daniel Douglas Von Hoff
Senior Vice President-Medical Affairs
Caroline M. Loewy
Director
Erich Maximilian Platzer
Independent Director
Warren Whitehead
Independent Director
Mark D. Vincent
Independent Director
Denis R. Burger
Lead Independent Director
| Address |
251 Consumers Road
Toronto Ontario M2J 4R3
Canada
|
|
Employees
|
- |
| Website |
http://aptose.com |
| Updated |
07/08/2019 |
| Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG'806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada. |
